Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-26 Sale | 2024-11-27 4:24 pm | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 44 | $4.865 | $214 | 235,066 (Indirect Direct) | View |
| 2024-03-15 Sale | 2024-03-19 2:30 pm | Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer | 50,000 | $6 | $300,000 | 984,476 (Direct) | View |
| 2024-03-08 Sale | 2024-03-12 1:45 pm | Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer | 25,000 | $5.1874 | $129,685 | 1,034,476 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-10 Tax Withholding | 2025-03-11 5:49 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer | 4,572 | $2.54 | 408,552 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:49 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer | 28,290 | $2.65 | 408,552 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:49 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer | 180,000 | $0 | 408,552 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 5:48 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 2,182 | $2.54 | 337,526 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:48 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 15,358 | $2.65 | 337,526 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:48 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 120,000 | $0 | 337,526 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:48 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Chief Financial Officer | 18,929 | $2.65 | 399,366 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:48 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Chief Financial Officer | 170,000 | $0 | 399,366 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:48 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer | 8,115 | $2.65 | 343,566 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:48 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer | 100,000 | $0 | 343,566 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:48 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry SVP Sales and Marketing | 5,428 | $2.65 | 194,572 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:48 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry SVP Sales and Marketing | 125,000 | $0 | 194,572 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:47 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Chief Legal Officer | 20,250 | $2.65 | 462,981 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:47 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Chief Legal Officer | 170,000 | $0 | 462,981 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:47 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. See Remark | 14,305 | $2.65 | 343,323 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:47 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. See Remark | 120,000 | $0 | 343,323 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:47 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 83,305 | $2.65 | 1,423,173 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:47 pm | N/A 2025-03-07 | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 680,000 | $0 | 1,423,173 (Direct) | View |
| 2024-12-02 Gift | 2024-12-04 4:47 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K 10% Owner | 40,000 | $0 | 10,026,111 (Indirect) | View |
| 2024-03-09 Tax Withholding(A) | 2024-10-02 2:16 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer | 9,645 | $4.88 | 980,726 (Direct) | View |
| 2024-03-09 Tax Withholding(A) | 2024-10-02 2:15 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer | 19,505 | $4.88 | 261,414 (Direct) | View |
| 2024-03-09 Tax Withholding(A) | 2024-10-02 2:15 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 56,824 | $4.88 | 826,478 (Direct) | View |
| 2024-03-09 Tax Withholding(A) | 2024-10-02 2:14 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Jung Cassie SVP, Operations | 14,120 | $4.88 | 235,110 (Direct) | View |
| 2024-08-09 Tax Withholding | 2024-08-12 2:45 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer | 10,819 | $3.43 | 251,681 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-21 1:51 pm | 2025-06-20 2034-06-20 | Aquestive Therapeutics Inc. | AQST | MORRIS TIMOTHY E Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-21 1:51 pm | 2025-06-20 2034-06-20 | Aquestive Therapeutics Inc. | AQST | Taglietti Marco Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-21 1:51 pm | 2025-06-20 2034-06-20 | Aquestive Therapeutics Inc. | AQST | BROWN GREGORY B Director | 38,000 | $0 | 113,085 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-21 1:50 pm | 2025-06-20 2034-06-20 | Aquestive Therapeutics Inc. | AQST | Krop Julie Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-21 1:50 pm | 2025-06-20 2034-06-20 | Aquestive Therapeutics Inc. | AQST | Cochran John Director | 38,000 | $0 | 137,486 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-21 1:50 pm | 2025-06-20 2034-06-20 | Aquestive Therapeutics Inc. | AQST | COSTA SANTO J Director | 38,000 | $0 | 55,327 (Direct) | View |
Ownership(A) | 2024-06-12 5:14 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry SVP Sales and Marketing | 0 | $0 | 50,000 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 12:36 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry SVP Sales and Marketing | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2024-06-11 12:35 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry SVP Sales and Marketing | 0 | $0 | 0 (Direct) | View |
| 2024-05-10 Option Award | 2024-05-13 1:40 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer | 10,000 | $0 | 267,963 (Direct) | View |
| 2024-05-10 Option Award | 2024-05-13 1:40 pm | N/A 2034-05-10 | Aquestive Therapeutics Inc. | AQST | Jenkins Abigail L. Director | 57,000 | $0 | 57,000 (Direct) | View |
Ownership | 2024-04-26 09:20 am | N/A N/A | Aquestive Therapeutics Inc. | AQST | Jenkins Abigail L. Director | 0 | $0 | 0 (Direct) | View |
| 2024-03-09 Tax Withholding | 2024-03-12 1:47 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 37,938 | $4.88 | 845,364 (Direct) | View |
| 2024-03-09 Tax Withholding | 2024-03-12 1:47 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. See Remark | 8,370 | $4.88 | 237,628 (Direct) | View |
| 2024-03-09 Tax Withholding | 2024-03-12 1:47 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J SVP, General Counsel | 10,530 | $4.88 | 313,231 (Direct) | View |
| 2024-03-09 Tax Withholding | 2024-03-12 1:47 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer | 11,705 | $4.88 | 248,295 (Direct) | View |
| 2024-03-09 Tax Withholding | 2024-03-12 1:46 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen SVP, Research & Development | 12,956 | $4.88 | 257,963 (Direct) | View |
| 2024-03-09 Tax Withholding | 2024-03-12 1:46 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Jung Cassie SVP, Operations | 9,432 | $4.88 | 239,798 (Direct) | View |
| 2024-03-09 Tax Withholding | 2024-03-12 1:45 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer | 5,895 | $4.88 | 1,034,476 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-11 10:36 am | N/A 2034-03-07 | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J SVP, General Counsel | 202,500 | $0 | 391,261 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-11 10:36 am | N/A 2034-03-07 | Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer | 180,000 | $0 | 320,000 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-11 10:36 am | N/A 2034-03-07 | Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer | 123,750 | $0 | 1,106,621 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-11 10:35 am | N/A 2034-03-07 | Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer | 168,750 | $0 | 318,750 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-11 10:35 am | N/A 2034-03-07 | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 606,500 | $0 | 1,247,202 (Direct) | View |